4UIT
BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-2-(4- methanesulfonylpiperazine-1-carbonyl)-5-methyl-4H,5H-thieno-3,2-c- pyridin-4-one
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I02 |
Synchrotron site | Diamond |
Beamline | I02 |
Temperature [K] | 100 |
Collection date | 2012-09-19 |
Spacegroup name | P 1 |
Unit cell lengths | 24.700, 34.110, 39.680 |
Unit cell angles | 70.26, 73.80, 74.24 |
Refinement procedure
Resolution | 36.540 - 1.300 |
R-factor | 0.15331 |
Rwork | 0.152 |
R-free | 0.17300 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | NONE |
RMSD bond length | 0.007 |
RMSD bond angle | 1.122 |
Data scaling software | SCALA |
Refinement software | REFMAC (5.6.0117) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 36.540 | 1.370 |
High resolution limit [Å] | 1.300 | 1.300 |
Rmerge | 0.030 | 0.050 |
Number of reflections | 23127 | |
<I/σ(I)> | 19.4 | 12.7 |
Completeness [%] | 81.9 | 51.8 |
Redundancy | 1.9 | 1.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 293 | 0.2M ZNAC, 20% PEG3350 20C |